Mitotane is indicated for the treatment of patients with inoperable, functional or nonfunctional, adrenocortical carcinoma (ACC).
from FDA,2024.01
Understanding the applicability and usage of mitotane is of great significance f···【more】
Release date:2025-04-28Recommended:8
Understanding the indications of the drug is a prerequisite for rational drug us···【more】
Release date:2025-04-28Recommended:11
Treatment options for a specific endocrine disorder are often of clinical concer···【more】
Release date:2025-04-27Recommended:13
The commonly used dosage form of Mitotane is a tablet, which is an antineoplasti···【more】
Release date:2024-08-16Recommended:107
By inhibiting the synthesis of adrenocortical hormones, Mitotane slows or stops ···【more】
Release date:2024-08-16Recommended:144
Mitotane is a drug with a unique mechanism of action that plays an important rol···【more】
Release date:2024-08-16Recommended:112